BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sutton JM, Abbott DE. Neoadjuvant therapy for pancreas cancer: Past lessons and future therapies. World J Gastroenterol 2014; 20(42): 15564-15579 [PMID: 25400440 DOI: 10.3748/wjg.v20.i42.15564]
URL: https://www.wjgnet.com/1948-5204/full/v20/i42/15564.htm
Number Citing Articles
1
Véronique Vendrely, Evelyne Peuchant, Etienne Buscail, Isabelle Moranvillier, Benoit Rousseau, Aurélie Bedel, Aurélia Brillac, Hubert de Verneuil, François Moreau-Gaudry, Sandrine Dabernat. Resveratrol and capsaicin used together as food complements reduce tumor growth and rescue full efficiency of low dose gemcitabine in a pancreatic cancer modelCancer Letters 2017; 390: 91 doi: 10.1016/j.canlet.2017.01.002
2
Meifen Chu, Tongtong Wang, Aihua Sun, Yu Chen. Nimesulide inhibits proliferation and induces apoptosis of pancreatic cancer cells by enhancing expression of PTENExperimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6191
3
Todd Crocenzi, Benjamin Cottam, Pippa Newell, Ronald F. Wolf, Paul D. Hansen, Chet Hammill, Matthew C. Solhjem, Yue-Yun To, Amy Greathouse, Garth Tormoen, Zeljka Jutric, Kristina Young, Keith S. Bahjat, Michael J. Gough, Marka R. Crittenden. A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinomaJournal for ImmunoTherapy of Cancer 2016; 4(1) doi: 10.1186/s40425-016-0149-6
4
Ethan Song, Daniel Segarra, Kujtim Latifi, Susan Leuthold, Dalila Belinc, Luis Pena, Mokenge P. Malafa, Jessica M. Frakes, Sarah E. Hoffe. Recognition of Tumor Invasion of a Pancreatic Head Biliary Stent During Stereotactic Body Radiation TherapyPractical Radiation Oncology 2019; 9(3): 132 doi: 10.1016/j.prro.2019.01.008
5
Masayuki Sho, Takahiro Akahori, Toshihiro Tanaka, Shoichi Kinoshita, Minako Nagai, Tetsuro Tamamoto, Chiho Ohbayashi, Masatoshi Hasegawa, Kimihiko Kichikawa, Yoshiyuki Nakajima. Importance of resectability status in neoadjuvant treatment for pancreatic cancerJournal of Hepato-Biliary-Pancreatic Sciences 2015; 22(7): 563 doi: 10.1002/jhbp.258
6
Brent T. Xia, David A. Habib, Vikrom K. Dhar, Nick C. Levinsky, Young Kim, Dennis J. Hanseman, Jeffrey M. Sutton, Gregory C. Wilson, Milton Smith, Kyuran Ann Choe, Jeffrey J. Sussman, Syed A. Ahmad, Daniel E. Abbott. Early Recurrence and Omission of Adjuvant Therapy after Pancreaticoduodenectomy Argue against a Surgery-First ApproachAnnals of Surgical Oncology 2016; 23(13): 4156 doi: 10.1245/s10434-016-5457-z
7
Sameer H. Patel, Matthew H. G. Katz, Syed A. Ahmad. The Landmark Series: Preoperative Therapy for Pancreatic CancerAnnals of Surgical Oncology 2021; 28(8): 4104 doi: 10.1245/s10434-021-10075-1
8
Cheng-Jeng Tai, Ming-Te Huang, Chih-Hsiung Wu, Chien-Kai Wang, Chen-Jei Tai, Chun-Chao Chang, Cheng-I. Hsieh, Yu-Jia Chang, Chang-Jer Wu, Li-Jen Kuo, Po-Lei Wei, Ray-Jade Chen, Hung-Yi Chiou. Combination of Two Targeted Medications (Bevacizumab Plus Cetuximab) Improve the Therapeutic Response of Pancreatic CarcinomaMedicine 2016; 95(15): e3259 doi: 10.1097/MD.0000000000003259
9
Satoshi Okubo, Motohiro Kojima, Yoko Matsuda, Masayoshi Hioki, Yasuhiro Shimizu, Hirochika Toyama, Soichiro Morinaga, Naoto Gotohda, Katsuhiko Uesaka, Genichiro Ishii, Mari Mino-Kenudson, Shinichiro Takahashi. Area of residual tumor (ART) can predict prognosis after post neoadjuvant therapy resection for pancreatic ductal adenocarcinomaScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53801-2
10
Catherine M. Sielaff, Shaker A. Mousa. Status and future directions in the management of pancreatic cancer: potential impact of nanotechnologyJournal of Cancer Research and Clinical Oncology 2018; 144(7): 1205 doi: 10.1007/s00432-018-2651-3
11
Sanguine Byun, Seung Ho Shin, Eunjung Lee, Jihoon Lee, Sung-Young Lee, Lee Farrand, Sung Keun Jung, Yong-Yeon Cho, Soo-Jong Um, Hong-Sig Sin, Youn-Ja Kwon, Chengjuan Zhang, Benjamin K. Tsang, Ann M. Bode, Hyong Joo Lee, Ki Won Lee, Zigang Dong. The retinoic acid derivative, ABPN, inhibits pancreatic cancer through induction of Nrdp1Carcinogenesis 2015; : bgv148 doi: 10.1093/carcin/bgv148
12
Kentaro Miyake, Ryutaro Mori, Yuki Homma, Ryusei Matsuyama, Akiko Okayama, Takashi Murakami, Hisashi Hirano, Itaru Endo. MZB1 in borderline resectable pancreatic cancer resected after neoadjuvant chemoradiotherapyJournal of Surgical Research 2017; 220: 391 doi: 10.1016/j.jss.2017.07.003
13
Christian Caglevic Medina, Sergio Panay Serra, Carlos Gallardo Araneda A, Jaime Anabalon Toha, Elizabeth Milla Ramirez, Mauricio Mahave Caceres. Advances in Pancreatic Cancer2018;  doi: 10.5772/intechopen.75739
14
Nicolò Pecorelli, Sara Nobile, Stefano Partelli, Luca Cardinali, Stefano Crippa, Gianpaolo Balzano, Luigi Beretta, Massimo Falconi. Enhanced recovery pathways in pancreatic surgery: State of the artWorld Journal of Gastroenterology 2016; 22(28): 6456-6468 doi: 10.3748/wjg.v22.i28.6456
15
Renu K. Virk, Roberto Gamez, Swati Mehrotra, Mohammed Atieh, Güliz A. Barkan, Eva M. Wojcik, Stefan E. Pambuccian. Variation of cytopathologists' use of the indeterminate diagnostic categories “atypical” and “suspicious for malignancy” in the cytologic diagnosis of solid pancreatic lesions on endoscopic ultrasound-guided fine-needle aspiratesDiagnostic Cytopathology 2017; 45(1): 3 doi: 10.1002/dc.23565
16
Sivesh K. Kamarajah, James R. Bundred, Charles Boyle, June Oo, Sanjay Pandanaboyana, Benjamin Loveday. Impact of neoadjuvant therapy on post‐operative pancreatic fistula: a systematic review and meta‐analysis ANZ Journal of Surgery 2020; 90(11): 2201 doi: 10.1111/ans.15885
17
Matthew R Zeiderman, Desiree E. Morgan, John D. Christein, William E. Grizzle, Kelly M. McMasters, Lacey R. McNally. Acidic pH-Targeted Chitosan-Capped Mesoporous Silica Coated Gold Nanorods Facilitate Detection of Pancreatic Tumors via Multispectral Optoacoustic TomographyACS Biomaterials Science & Engineering 2016; 2(7): 1108 doi: 10.1021/acsbiomaterials.6b00111
18
Philipp Nitschke, Andreas Volk, Thilo Welsch, Jonas Hackl, Christoph Reissfelder, Mohammad Rahbari, Marius Distler, Hans-Detlev Saeger, Jürgen Weitz, Nuh N. Rahbari. Impact of Intraoperative Re-resection to Achieve R0 Status on Survival in Patients With Pancreatic CancerAnnals of Surgery 2017; 265(6): 1219 doi: 10.1097/SLA.0000000000001808
19
Nicolò Pecorelli, Giovanni Capretti, Marta Sandini, Anna Damascelli, Giulia Cristel, Francesco De Cobelli, Luca Gianotti, Alessandro Zerbi, Marco Braga. Impact of Sarcopenic Obesity on Failure to Rescue from Major Complications Following Pancreaticoduodenectomy for Cancer: Results from a Multicenter StudyAnnals of Surgical Oncology 2018; 25(1): 308 doi: 10.1245/s10434-017-6216-5
20
Iván A. González, Liang-I Kang, Gregory A. Williams, Jingxia Liu, David G. DeNardo, William G. Hawkins, Deyali Chatterjee. Tumor-insular Complex in Neoadjuvant Treated Pancreatic Ductal Adenocarcinoma Is Associated With Higher Residual TumorAmerican Journal of Surgical Pathology 2020; 44(6): 817 doi: 10.1097/PAS.0000000000001454
21
Shikha Gulati, Sanjay Kumar, Parinita Singh, Anchita Diwan, Ayush Mongia. Handbook of Polymer and Ceramic Nanotechnology2020; : 1 doi: 10.1007/978-3-030-10614-0_56-1
22
Shikha Gulati, Sanjay Kumar, Parinita Singh, Anchita Diwan, Ayush Mongia. Handbook of Polymer and Ceramic Nanotechnology2021; : 811 doi: 10.1007/978-3-030-40513-7_56
23
Jordan M. Cloyd, Matthew H. G. Katz, Laura Prakash, Gauri R. Varadhachary, Robert A. Wolff, Rachna T. Shroff, Milind Javle, David Fogelman, Michael Overman, Christopher H. Crane, Eugene J. Koay, Prajnan Das, Sunil Krishnan, Bruce D. Minsky, Jeffrey H. Lee, Manoop S. Bhutani, Brian Weston, William Ross, Priya Bhosale, Eric P. Tamm, Huamin Wang, Anirban Maitra, Michael P. Kim, Thomas A. Aloia, Jean-Nicholas Vauthey, Jason B. Fleming, James L. Abbruzzese, Peter W. T. Pisters, Douglas B. Evans, Jeffrey E. Lee. Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution ExperienceJournal of Gastrointestinal Surgery 2017; 21(1): 164 doi: 10.1007/s11605-016-3265-1
24
Jong-chan Lee, Soyeon Ahn, Kyu-hyun Paik, Hyoung Woo Kim, Jingu Kang, Jaihwan Kim, Jin-Hyeok Hwang. Clinical impact of neoadjuvant treatment in resectable pancreatic cancer: a systematic review and meta-analysis protocolBMJ Open 2016; 6(3): e010491 doi: 10.1136/bmjopen-2015-010491
25
Kathleen K. Christians, Jonathan W. Heimler, Ben George, Paul S. Ritch, Beth A. Erickson, Fabian Johnston, Parag P. Tolat, William D. Foley, Douglas B. Evans, Susan Tsai. Survival of patients with resectable pancreatic cancer who received neoadjuvant therapySurgery 2016; 159(3): 893 doi: 10.1016/j.surg.2015.09.018
26
Gebremariam Birhanu, Hamid Akbari Javar, Ehsan Seyedjafari, Ali Zandi-Karimi. Nanotechnology for delivery of gemcitabine to treat pancreatic cancerBiomedicine & Pharmacotherapy 2017; 88: 635 doi: 10.1016/j.biopha.2017.01.071
27
Alexander V. Fisher, Daniel E. Abbott, Sara Fernandes-Taylor, Jeffrey A. Havlena, Xing Wang, Ying Shan, Elise H. Lawson, Emily R. Winslow, Sharon M. Weber, Jessica R. Schumacher. Cohort Study of Overutilization of Preventive Screening for Patients With Pancreatic CancerPancreas 2018; 47(9): e65 doi: 10.1097/MPA.0000000000001131
28
John R. Bergquist, Carlos A. Puig, Christopher R. Shubert, Ryan T. Groeschl, Elizabeth B. Habermann, Michael L. Kendrick, David M. Nagorney, Rory L. Smoot, Michael B. Farnell, Mark J. Truty. Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database StudyJournal of the American College of Surgeons 2016; 223(1): 52 doi: 10.1016/j.jamcollsurg.2016.02.009
29
Youyao Xu, Yizhen Chen, Fang Han, Jia Wu, Yuhua Zhang. Neoadjuvant therapy <i>vs</i>. upfront surgery for resectable pancreatic cancer: An update on a systematic review and meta-analysisBioScience Trends 2021;  doi: 10.5582/bst.2021.01459
30
Sheikh Hasibur Rahman, Robin Urquhart, Michele Molinari. Neoadjuvant therapy for resectable pancreatic cancerWorld Journal of Gastrointestinal Oncology 2017; 9(12): 457-465 doi: 10.4251/wjgo.v9.i12.457
31
Shin Hye Hwang, Mi-Suk Park. Radiologic Evaluation for Resectability of Pancreatic AdenocarcinomaJournal of the Korean Society of Radiology 2021; 82(2): 315 doi: 10.3348/jksr.2021.0019